For those diagnosed with type-2 diabetes who were looking for a reason to explore weight loss surgery as a means of controlling their diabetes or even putting it into remission, look no further than the July 1 issue of JAMA Surgery.
Sell Your Test Strips for Cash
Sell Your Test Strips With Confidence. We Offer Top Prices, Free Shipping, Fast Payments.
www.assistdiabetics.com
We Buy Your Unused Test Strips
Do You Have Unused Diabetes Test Strips? Get Cash Fast For Your Test Strips. Earn Money Today.
www.assistdiabetics.com/sell/test/strips
There, a study by Dr. Anita P. Courcoulas, of the University of Pittsburgh Medical Center, PA, and colleagues suggests that weight-loss surgery, combined with low-level lifestyle interventions, is more effective as a treatment strategy for obese patients with type 2 diabetes than lifestyle interventions alone.
They reached this conclusion by recruiting 61 obese patients aged 25-55 diagnosed with type-2 diabetes whom they randomly assigned to receive:
Those who were assigned to surgery received either roux-en-Y gastric bypass (RYGB) or laparoscopic adjustable gastric banding (LAGB).
These surgical interventions achieve the same ends-- limiting the amount of food that can be consumed, leading to feeling 'full' sooner-- but do it through different mechanisms. In RYGB, surgeons create a small stomach pouch from a portion of the stomach and connect it to the small intestine, bypassing the rest of the stomach and the duodenum. In LAGB, surgeons place a band around the upper part of the stomach to create a smaller stomach pouch.
The research team was looking for instances of partial or complete remission from type-2 diabetes among the entire group after three years. This was the primary endpoint, and here is what they found:
They concluded that this study "provides further important evidence that at longer-term follow-up of 3 years, surgical treatments, including RYGB and LAGB, are superior to lifestyle intervention alone for the remission of T2DM in obese individuals including those with a BMI between 30 and 35."
Note: It is important to take into consideration that the study's lead investigator, Dr Courcoulas, reported potential conflicts of interest in the following: she has received grants from Nutrisystem, J&J Ethicon (a part of Johnson and Johnson, Ehticon's purpose is to "advance innovation in surgery") and medical supplies and devices company Covidien. Covidien and Allergan, maker of the LAP-BAND(R) Adjustable Gastric Banding System, have had a long-standing agreement to jointly promote the lap-band system.
Additionally, Dr Courcoulas is a project consultant for Ethicon and Apollo Endosurgery.
Source: JAMA Surgery
Get a free 7-Day Diabetes Meal Plan from Constance Brown-Riggs who is a Registered Dietitian-Certified Diabetes Educator and who is also a national spokesperson for the American Dietetic Association.
Just enter in your email below to download your free Diabetes Meal Plan.